NUS Stock Overview
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Nu Skin Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.90 |
| 52 Week High | US$36.40 |
| 52 Week Low | US$11.20 |
| Beta | 1.1 |
| 1 Month Change | 5.31% |
| 3 Month Change | -28.74% |
| 1 Year Change | -67.13% |
| 3 Year Change | -73.40% |
| 5 Year Change | -73.57% |
| Change since IPO | -41.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUS | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 3.5% | 4.4% | 1.7% |
| 1Y | -67.1% | -2.0% | 2.3% |
Return vs Industry: NUS underperformed the German Personal Products industry which returned -2.8% over the past year.
Return vs Market: NUS underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| NUS volatility | |
|---|---|
| NUS Average Weekly Movement | 8.4% |
| Personal Products Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NUS's share price has been volatile over the past 3 months.
Volatility Over Time: NUS's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 3,700 | Ryan Napierski | www.nuskin.com |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+.
Nu Skin Enterprises, Inc. Fundamentals Summary
| NUS fundamental statistics | |
|---|---|
| Market cap | €591.68m |
| Earnings (TTM) | €8.03m |
| Revenue (TTM) | €1.84b |
72.1x
P/E Ratio0.3x
P/S RatioIs NUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUS income statement (TTM) | |
|---|---|
| Revenue | US$1.97b |
| Cost of Revenue | US$546.15m |
| Gross Profit | US$1.42b |
| Other Expenses | US$1.41b |
| Earnings | US$8.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 72.26% |
| Net Profit Margin | 0.44% |
| Debt/Equity Ratio | 61.2% |
How did NUS perform over the long term?
See historical performance and comparison